$307Million | No. of Holdings #13
Pivotal bioVenture Partners Investment Advisor LLC Performance
| Ticker | $ Bought |
|---|---|
| avalyn pharmaceuticals inc | 31,826,800 |
| Ticker | % Inc. |
|---|---|
| avalo therapeutics inc | 46.67 |
| trevi therapeutics inc | 12.16 |
| vaxcyte inc | 3.87 |
| Ticker | % Reduced |
|---|---|
| zenas biopharma inc | -17.1 |
| oculis holding ag | -10.36 |
| arcutis biotherapeutics inc | -6.68 |
| maplight therapeutics inc | 0.00 |
| Ticker | $ Sold |
|---|---|
| bolt biotherapeutics inc | -172,027 |
Pivotal bioVenture Partners Investment Advisor LLC has about 58.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 58.2 |
| Others | 41.8 |
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 53.3 |
| UNALLOCATED | 41.8 |
| SMALL-CAP | 3.3 |
| MICRO-CAP | 1.6 |
About 50.5% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 50.5 |
| Others | 49.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Pivotal bioVenture Partners Investment Advisor LLC has 13 stocks in it's portfolio. About 95.1% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. TRVI was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Arcutis Biotherapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Arcutis Biotherapeutics Inc over time | 10.78% | 1,265,280 | $33.18M 10.78% | 6.68%decreased 6.68 percentreduced | |
Avalo Therapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Avalo Therapeutics Inc over time | 2.61% | 434,033 | $8.02M 2.61% | 46.67%increased 46.67 percentadded | |
Bolt Biotherapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Bolt Biotherapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Immunome Inc Immunome IncIMNM Pivotal bioVenture Partners Investment Advisor LLC's holding in Immunome Inc over time | 5.04% | 732,512 | $15.52M 5.04% | 0%unchanged 0 percentunchanged | |
Vaxcyte Inc Vaxcyte IncPCVX Pivotal bioVenture Partners Investment Advisor LLC's holding in Vaxcyte Inc over time | 26.92% | 1,425,470 | $82.86M 26.92% | 3.87%increased 3.87 percentadded | |
Rallybio Corp Rallybio CorpRLYB Pivotal bioVenture Partners Investment Advisor LLC's holding in Rallybio Corp over time | 1.56% | 300,579 | $4.81M 1.56% | 0%unchanged 0 percentunchanged | |
Recursion Pharmaceuticals In Pivotal bioVenture Partners Investment Advisor LLC's holding in Recursion Pharmaceuticals In over time | 0.71% | 595,518 | $2.19M 0.71% | 0%unchanged 0 percentunchanged | |
Trevi Therapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Trevi Therapeutics Inc over time | 10.56% | 1,742,670 | $32.50M 10.56% | 12.16%increased 12.16 percentadded | |
Com Shs Avalyn Pharmaceuticals IncAvalyn Pharmaceuticals Inc | 10.34% | 966,792 | $31.83M 10.34% | Newnew position | |
Com Shs Evommune IncEvommune Inc | 8.32% | 1,926,940 | $25.61M 8.32% | 0%unchanged 0 percentunchanged | |
Com Maplight Therapeutics IncMaplight Therapeutics Inc | 7.12% | 611,446 | $21.91M 7.12% | 0%unchanged 0 percentreduced | |
Ordinary Shares Oculis Holding AgOculis Holding Ag | 6.79% | 1,506,250 | $20.89M 6.79% | 10.36%decreased 10.36 percentreduced | |
Com Bioage Labs IncBioage Labs Inc | 5.2% | 653,374 | $16.01M 5.2% | 0%unchanged 0 percentunchanged | |
Com Zenas Biopharma IncZenas Biopharma Inc | 4.05% | 490,766 | $12.46M 4.05% | 17.1%decreased 17.1 percentreduced | |